Company intelligence / Profile preview

NYrture

Brooklyn, New York, United States

Ownership: Private
Development stage: Other

Overview

NYrture is a New York-based biotechnology and functional food company that specializes in the production of fresh, scientifically-validated natto. Founded by microbiologist Dr. Ann Yonetani, the company leverages microbial fermentation to provide high-potency natural sources of nattokinase and Vitamin K2 (MK-7). Their products are designed to support cardiovascular, bone, and gut health through the delivery of live Bacillus subtilis var. natto cultures. NYrture bridges the gap between traditional fermented foods and modern probiotic science, catering to health-conscious consumers and the preventive healthcare market.

Therapeutic areas: EndocrinologyCardiovascularImmunologyGastroenterology
Modalities: Live biotherapeutic product therapyMicrobial therapy
Industry: Food & Nutrition

Beyond the preview

Go deeper on NYrture.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NYrture.

Explore the full profile